Anesthetic Risk Assessment in Laboratory Animals: Preoperative Evaluation

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Anesthetic risk assessment in laboratory animals is a structured, species-specific process prioritizing experimental objectives alongside welfare obligations. The core question is whether the anticipated benefit of the procedure justifies the anesthetic risk, necessitating a reproducible pathway accounting for baseline health, experimental demands, and cumulative anesthetic exposures.
• Severity classification (e.g., EU Directive 2010/63) and adapted ASA physical status are critical for stratifying risk and determining monitoring intensity. Severity classification dictates monitoring intensity and humane endpoints, while the adapted ASA status (I-V, E) incorporates experimental context to predict perioperative complication probability and guide management.
• Patient-specific factors like age, neurodevelopmental stage, and prior anesthetic exposure significantly modify risk. Immature brains are susceptible to anesthetic-induced neuronal apoptosis, and repeated anesthetic episodes, even with short intervals, can cumulatively impact well-being, necessitating careful history taking.
• Species and strain predispositions, along with experimental variables, demand tailored anesthetic plans. Known anesthetic sensitivities, pharmacogenetic traits, and procedure-specific demands (e.g., fasting, surgical manipulation) require careful consideration and consultation of species-specific resources like the MSD Veterinary Manual.
• Comprehensive documentation of the preoperative assessment, risk classification, and planned anesthetic protocol is mandatory for clinical continuity and regulatory compliance. This includes recording identified risk factors, planned monitoring, and intervention thresholds to guide anesthetists and demonstrate prospective welfare assessment.
• Early detection of common complications such as hypothermia, hypotension, and hypoventilation relies on continuous monitoring and understanding species-specific signs. Hypothermia is prevalent due to high surface area to volume ratio, while hypotension may be occult in rodents, requiring reliance on indirect perfusion markers and Doppler ultrasound.

Anesthetic risk assessment in laboratory animals is a structured clinical process that integrates species-specific physiology, experimental variables, and institutional oversight requirements. This article provides a systematic framework for the preoperative evaluation of laboratory animals across common research species, with emphasis on risk stratification, patient assessment, and documentation of decisions. It serves veterinary researchers and clinical veterinarians who must balance experimental objectives with welfare obligations under the 3R Principle of Replacement, Reduction, and Refinement.

The central clinical question is not whether an animal can be anesthetized, but whether the anticipated benefit of the procedure justifies the probability and magnitude of anesthetic morbidity or mortality for that individual animal. Answering this question requires a reproducible assessment pathway that accounts for baseline health, procedure-specific demands, and the cumulative effects of repeated anesthetic exposures. The framework presented here follows the logic of preoperative risk stratification used in clinical veterinary medicine, adapted to the constraints and objectives of research settings.

At a Glance

Conceptual Basis of Risk Stratification

Risk assessment in laboratory animal anesthesia differs from companion animal practice in one fundamental respect: the procedure itself is dictated by the experimental protocol, not by therapeutic necessity. The veterinarian therefore evaluates risk within a framework where the intervention is fixed and the animal is selected for it. This reverses the usual clinical logic and places greater weight on pre-screening, exclusion criteria, and refinement of the anesthetic plan to match the animal to the procedure.

The severity classification system established by EU Directive 2010/63 provides the regulatory scaffold for this assessment. Procedures are categorized as non-recovery, mild, moderate, or severe, and the classification directly influences the intensity of perioperative monitoring and the threshold for intervention. A systematic assessment protocol for mice undergoing general anesthesia, developed by Hohlbaum and colleagues, demonstrates how this classification translates into practical welfare monitoring using home cage activity, the Mouse Grimace Scale, and luxury behaviors such as burrowing and nest building. These tools detect post-anesthetic welfare compromise that routine clinical observation may miss, particularly in the 24-hour period following recovery.

Patient Factors That Modify Risk

Age and Neurodevelopmental Vulnerability

The immature brain is uniquely susceptible to anesthetic-induced neuronal apoptosis. Loepke and Soriano reviewed evidence from multiple immature animal models demonstrating degenerative effects of commonly used anesthetics on neuronal structure, with some studies reporting cognitive impairment in adult animals after neonatal anesthesia. The translational relevance to clinical pediatric anesthesia remains uncertain, but for laboratory animal protocols involving neonatal or juvenile animals, this evidence mandates caution. Preoperative assessment of young animals should include documentation of developmental stage, body weight relative to age-matched norms, and consideration of whether the procedure can be delayed until neural maturation is more advanced.

Repeated Anesthetic Exposure

Research protocols increasingly require serial imaging or sampling procedures that necessitate repeated anesthesia in the same animal. The severity classification in EU Directive 2010/63 does not differentiate between single and repeated anesthesia, yet repeated exposure may have a greater cumulative impact on well-being. Hohlbaum and colleagues compared single versus six repeated ketamine-xylazine anesthesias in C57BL/6JRj mice and found that repeated anesthesia increased Mouse Grimace Scale scores in both sexes and caused short-term welfare effects in females during the immediate post-anesthetic period. Preoperative evaluation for any anesthetic episode should therefore include a complete history of prior exposures, with particular attention to intervals shorter than three to four days and to agents with known cumulative effects.

Species and Strain Predispositions

Laboratory species differ substantially in their physiologic responses to anesthetic agents, and strain-level differences within species can be as significant as interspecies variation. The preoperative assessment must incorporate species-specific reference ranges for cardiorespiratory parameters, known drug metabolism pathways, and documented anesthetic sensitivities. The MSD Veterinary Manual provides peer-reviewed species-specific guidance that is directly applicable to common laboratory species including rodents, rabbits, and ferrets. For less common research species, the attending veterinarian should consult institutional records and current literature before finalizing an anesthetic plan.

Procedure-Related Risk Factors

The nature of the experimental procedure modifies anesthetic risk independently of patient factors. Surgical procedures involving body cavity entry, hemorrhage, or prolonged positioning carry higher risk than brief non-invasive imaging. The preoperative assessment must therefore include a detailed review of the approved animal use protocol, with specific attention to the expected duration of anesthesia, the degree of surgical stimulation, and the requirement for specific positioning that may compromise ventilation or perfusion.

Fasting requirements deserve particular scrutiny. Many laboratory animal protocols impose preoperative fasting based on extrapolation from human or companion animal practice, but the evidence base for fasting in small rodents is limited, and the risk of hypoglycemia and dehydration may outweigh the benefit of reduced gastric content. The assessment should weigh these competing risks for each species and procedure, and the decision should be documented in the anesthetic record.

Institutional and Regulatory Context

Preoperative risk assessment operates within an institutional framework that includes the animal care and use committee, institutional veterinary staff, and applicable regulatory standards. The Guide for the Care and Use of Laboratory Animals published by the National Research Council establishes the expectation that veterinary care programs include pre-procedural assessment and that institutional policies support appropriate perioperative monitoring. The NC3Rs provides practical guidance on refinement of anesthetic and surgical procedures that can directly inform preoperative planning.

Occupational exposure is an additional consideration that influences agent selection. Isoflurane and other volatile anesthetics present measurable occupational health risks, and a systematic review protocol has been developed to establish a health-based recommended occupational exposure limit for isoflurane using controlled animal exposure data. Preoperative planning should include verification that scavenging systems are functional and that personnel exposure monitoring is in place, as these factors determine which inhalation agents can be used safely in a given facility.

Documentation and Decision Recording

The preoperative assessment should be documented in a format that supports both clinical continuity and regulatory review. The record should include the severity classification, the assigned physical status category, specific risk factors identified, the planned anesthetic approach, and the monitoring and intervention thresholds that will trigger modification of the plan. This documentation serves the dual purpose of guiding the anesthetist during the procedure and demonstrating compliance with institutional and regulatory expectations for prospective welfare assessment.

Pre-Anesthetic Assessment Sequence

The preoperative evaluation proceeds through a defined sequence that balances completeness against the constraints of working with laboratory species. The sequence begins with record review, moves to a period of undisturbed observation, proceeds to hands-on examination, and concludes with risk classification and anesthetic planning. Each step generates information that may alter the final risk assignment.

Record review should capture the animal's genetic background, health surveillance status, experimental history, and any prior anesthetic events. For genetically modified lines, the phenotype may include traits relevant to anesthetic risk, such as cardiomyopathy in some muscular dystrophy models or altered drug metabolism in cytochrome P450 knockout strains. The health surveillance records from the vendor and the institution's sentinel program establish the microbiological status of the colony, which determines whether the animal is immunocompetent, specific pathogen free, or carrying agents that could complicate anesthesia.

Observation before handling provides information that handling itself will obscure. Respiratory rate and pattern, posture, grooming behavior, and response to environmental stimuli are all assessable without disturbing the animal. A mouse that is hunched, piloerect, or reluctant to move may be in pain or distress that would otherwise be attributed to handling. The systematic well-being assessment protocol developed for mice under general anesthesia incorporates home cage activity, burrowing, nest building, and the Mouse Grimace Scale as indicators that can be scored before and after the procedure to detect deterioration Hohlbaum et al., systematic well-being assessment for mice under general anesthesia. These same measures, adapted to the species, inform the pre-anesthetic baseline against which post-anesthetic recovery will be judged.

The hands-on examination follows a species-appropriate format. Body weight is the single most informative measurement, as it establishes drug dose calculations, identifies cachexia or obesity, and provides a baseline for post-anesthetic monitoring. Body condition scoring, hydration status, mucous membrane color, capillary refill time, heart rate, respiratory rate, and auscultation of the heart and lungs form the core examination. For rodents, auscultation is technically challenging but feasible with a pediatric stethoscope or Doppler device. For rabbits, dental examination is mandatory, as dental disease is common and can impair airway management. For fish and amphibians, examination focuses on body condition, fin or skin integrity, gill or skin respiration, and buoyancy control.

Risk Classification and the ASA Status Adapted for Laboratory Species

The American Society of Anesthesiologists (ASA) physical status classification system provides a framework for communicating risk that is widely used in veterinary and laboratory animal medicine. The standard classification assigns a Roman numeral from I to V based on the severity of systemic disease, with E appended for emergency procedures. The classification does not predict anesthetic mortality directly, but it structures communication among personnel and flags animals that require additional monitoring or modified protocols.

For laboratory species, the classification requires adaptation because the underlying disease may be experimental instead of spontaneous, and because the animal's value to the study may influence decisions about intervention. The adapted classification below incorporates the experimental context into the physical status assignment.

The classification should be assigned at the time of pre-anesthetic assessment and recorded in the anesthetic record. If the animal's condition changes between assessment and procedure, the classification must be revised. The Guide for the Care and Use of Laboratory Animals requires that veterinary care programs document the condition of animals and the rationale for procedures, and the ASA assignment forms part of that documentation.

Equipment and Monitoring Selection Based on Risk Class

The ASA class determines the minimum monitoring standards and the equipment that must be available before anesthesia is induced. For ASA I animals undergoing short, non-recovery procedures, monitoring may be limited to observation of respiratory pattern and pedal reflexes. For ASA III and above, or for any procedure expected to exceed 30 minutes, physiologic monitoring becomes mandatory.

Core monitoring parameters for laboratory species include:

• Heart rate and rhythm: Palpation, auscultation, Doppler ultrasound, or electrocardiography. Bradycardia may indicate deep anesthetic planes, hypothermia, or vagal stimulation. Tachycardia may indicate inadequate depth, pain, hypovolemia, or hypercapnia.
• Respiratory rate and pattern: Visual observation, capnography, or respiratory inductance plethysmography. Apnea or irregular breathing patterns precede respiratory arrest.
• Oxygen saturation: Pulse oximetry, with the probe placed on the foot, tail, or ear depending on species. Motion artifact is common in rodents and may produce false readings.
• Temperature: Rectal or esophageal probes. Hypothermia is the most common anesthetic complication in small laboratory mammals because of their high surface area to volume ratio.
• Capnography: End-tidal carbon dioxide measurement, feasible in animals above approximately 300 g with appropriate airway adapters. It detects hypoventilation, airway obstruction, and equipment failure.
• Blood pressure: Doppler or oscillometric methods. Hypotension may indicate deep anesthesia, hemorrhage, or cardiovascular depression.

The selection of monitoring equipment depends on the species and body size. A mouse weighing 25 g cannot accommodate the same pulse oximetry probe as a rabbit weighing 3 kg. The anesthetic plan must specify which parameters will be monitored, at what intervals, and what interventions will follow abnormal readings. Personnel must be trained in the use of each monitoring device and must understand the artifacts and failure modes specific to the species and the device.

Decision Points and Protocol Modification

The pre-anesthetic assessment generates a risk classification, but the classification does not by itself determine the anesthetic protocol. The clinician must integrate the risk class with the procedural requirements, the available equipment, and the experimental objectives to select an approach.

The first decision point is whether to proceed, postpone, or cancel. An animal with an upper respiratory infection that requires imaging under anesthesia may be postponed until the infection resolves. An animal with a progressive experimental disease that has reached a humane endpoint may proceed with a modified protocol to collect terminal data. The decision must be recorded with the rationale, and the investigator must be consulted when postponement affects study timelines or data validity.

The second decision point is the choice of anesthetic drugs and route. Injectable protocols are standard for rodents because of ease of administration and minimal equipment requirements. Inhalational anesthesia offers greater control over depth and faster recovery but requires an induction chamber, precision vaporizer, and scavenging system. The NC3Rs resources on refinement of anesthetic procedures provide practical guidance on selecting protocols that minimize distress and optimize recovery.

The third decision point is the monitoring intensity and the criteria for intervention. For an ASA I mouse undergoing a 10-minute non-recovery procedure, monitoring may be observational. For an ASA III rat undergoing a 2-hour survival surgery, continuous monitoring with temperature support, fluid administration, and a defined response protocol for hypotension or bradycardia is required. The monitoring plan must be written before anesthesia begins, and all personnel must know their roles in executing it.

The fourth decision point occurs during recovery. The duration and quality of recovery determine whether the animal returns to its home cage or requires intensive care. The well-being assessment protocol for mice after anesthesia includes the Mouse Grimace Scale, nesting behavior, and home cage activity, all of which are sensitive to the effects of repeated anesthetic exposure Hohlbaum et al., repeated ketamine-xylazine anesthesia and mouse well-being. An animal that fails to regain normal behavior within the expected timeframe requires veterinary assessment and may need analgesia, fluid therapy, or environmental modification.

Documentation of the Risk Assessment

The anesthetic record must document the pre-anesthetic assessment, the risk classification, the planned protocol, and the monitoring parameters. The record serves three purposes: it communicates the plan to all personnel involved in the procedure, it provides a baseline for post-anesthetic comparison, and it creates a historical database for quality improvement.

The record should include the animal identification, genotype, age, body weight, and health surveillance status. The ASA class and the rationale for that assignment should be recorded. The planned anesthetic drugs, doses, routes, and reversal agents should be listed, with the caveat that current formulary references must be consulted for dose verification. The monitoring plan, including parameters, intervals, and intervention thresholds, should be specified. Finally, the record should note any deviations from the plan and the reasons for those deviations.

Institutional policies may require that the risk assessment be reviewed by the attending veterinarian or the animal care and use committee before certain procedures. The Guide for the Care and Use of Laboratory Animals specifies that the veterinary care program must provide guidance on anesthesia, analgesia, and surgery, and that the institution must ensure personnel are qualified to perform the procedures. The risk assessment documentation supports these requirements by demonstrating that the anesthetic plan was developed with appropriate veterinary oversight.

Recognized Complications and Early Detection

The most consequential anesthetic complications in laboratory animals are hypothermia, hypotension, hypoventilation, and prolonged recovery. Each has a characteriztic temporal signature that the astute clinician recognizes before overt decompensation.

Hypothermia develops within minutes of anesthetic induction because volatile agents and injectable combinations suppress hypothalamic thermoregulation, and small body mass accelerates heat loss. In mice, body temperature can fall below 35°C within 15 to 20 minutes of induction if active warming is not provided. Early detection requires continuous temperature monitoring via rectal probe or infrared thermometry, not intermittent palpation. The discriminating finding is a downward trend across consecutive readings instead of a single low value, because handling and probe placement cause transient fluctuations.

Hypotension is frequently occult in small rodents because noninvasive oscillometric devices perform poorly at low pressures and small cuff sizes. The earliest indicators are prolonged capillary refill time, pale mucous membranes, and reduced pulse quality assessed by Doppler ultrasound. In larger species such as rabbits and ferrets, direct arterial catheterization provides reliable pressure data, but in mice and rats the clinician must rely on indirect signs and tissue perfusion markers such as urine output and lactate trends. A falling heart rate under stable anesthetic depth, particularly with isoflurane or sevoflurane, suggests myocardial depression instead of deepening anesthesia.

Hypoventilation manifests as rising end-tidal carbon dioxide when capnography is available, or as shallow, irregular thoracic excursions when it is not. Pulse oximetry detects hypoxemia only after ventilation-perfusion mismatch is advanced, so it is a late indicator. The earliest reliable sign is a change in respiratory pattern, specifically a shift from regular abdominal breathing to rapid, shallow efforts with prolonged expiratory pauses. In species where capnography is impractical, serial blood gas analysis on small sample volumes provides definitive diagnosis.

Prolonged recovery is defined as failure to regain sternal recumbency within twice the expected duration for the specific agent and species. The most common causes are residual drug effect from hepatic or renal impairment, hypothermia delaying drug metabolism, and hypoglycemia in fasted animals. The Mouse Grimace Scale and home cage activity monitoring detect subtle post-anesthetic distress that overt clinical examination misses, and these tools integrate well into recovery assessment protocols Hohlbaum et al., systematic well-being assessment in mice.

Common Errors and Corrective Actions

Less experienced clinicians frequently misclassify anesthetic depth in small rodents because the margin between surgical anesthesia and respiratory arrest is narrow. The classic error is equating immobility with adequate depth. A mouse that is motionless but has a rapid, shallow respiratory rate and brisk pedal reflex is under-anesthetized, not adequately anesthetized. The corrective action is to assess the pedal withdrawal reflex and ear pinch response together with respiratory rate, and to titrate the inhalant agent in small increments instead of bolus doses.

A second recurring error is omitting pre-warming of the recovery environment. Clinicians often focus on the induction period and neglect that the immediate post-anesthetic period carries the highest mortality risk. Pre-warming a recovery cage to the species thermoneutral zone before the procedure begins, instead of after the animal is already hypothermic, is the correct sequence. Repeated anesthetic exposure compounds this risk, as studies in mice show that six ketamine-xylazine anesthetics at three to four day intervals increase grimace scores and produce short-term welfare effects that a single exposure does not repeated ketamine-xylazine anesthesia and mouse well-being.

A third error is failure to distinguish permissive hypothermia from pathologic hypothermia. Mild hypothermia to 36°C in a rat may reduce anesthetic requirements and is sometimes deliberately induced. However, the same temperature in a neonatal mouse represents significant thermal stress. The corrective action is to establish species-specific and age-specific temperature targets before induction and to document the acceptable range in the anesthetic record.

Limitations of the Evidence and Divergent Expert Opinion

The evidence base for anesthetic risk assessment in laboratory animals is uneven. Most controlled studies use healthy adult rodents, and extrapolation to aged, juvenile, or diseased animals rests on limited data. The neurodevelopmental vulnerability literature derives largely from rodent models, and the applicability of these findings to clinical anesthesia decisions remains contested effects of general anesthetics on developing brain structure. Some experts advocate delaying elective procedures in juvenile animals until neurodevelopmental milestones are reached, while others argue that the risk of withholding necessary procedures outweighs the uncertain neurotoxicity risk.

Expert opinion also diverges on the value of the adapted ASA status in laboratory species. Proponents argue that a standardized classification improves communication and documentation, while critics contend that the physiologic reserve of healthy laboratory rodents is so uniform that the classification adds little discrimination. The middle position, reflected in institutional guidance from bodies such as the NC3Rs practical refinement resources, is to use the ASA status as a communication tool instead of a predictive instrument.

Occupational exposure limits for waste anesthetic gases remain an area of active investigation, with systematic reviews underway to derive health-based recommendations from controlled animal studies systematic review protocol for isoflurane occupational exposure limits. Until these are finalized, institutional policies vary, and the clinician should follow local occupational health guidance.

Referral, Consultation, and Regulatory Reporting

Referral to a veterinary anesthesiologist or a laboratory animal specialist is warranted when the patient has a condition that the attending clinician has not previously managed under anesthesia, when physiologic parameters cannot be stabilized despite appropriate intervention, or when the procedure requires monitoring capabilities that the facility does not possess. Consultation with the institutional animal care and use committee is appropriate when a proposed protocol involves repeated anesthetic episodes, because the cumulative welfare impact may exceed the severity classification assigned to a single procedure Hohlbaum et al., repeated anesthesia welfare assessment.

Regulatory reporting obligations vary by jurisdiction. In the European Union, unexpected mortality or severe suffering during anesthesia must be reported to the competent authority as an adverse event. In the United States, the attending veterinarian and the institutional animal care and use committee must be notified of any unrelieved pain or distress, and the institutional official is responsible for ensuring corrective action. The Guide for the Care and Use of Laboratory Animals specifies that the program of veterinary care must include oversight of anesthetic procedures and that deviations from established protocols require documented justification.

Frequently Asked Questions

How Should I Adjust the Risk Assessment When Only Basic Monitoring Equipment Is Available?

When pulse oximetry, capnography, or blood pressure measurement is unavailable, the assessment shifts toward stricter patient selection and more conservative anesthetic planning. Reserve higher-risk procedures for animals with no identifiable comorbidities and use injectable protocols with wider safety margins. Physical examination findings, capillary refill time, mucous membrane color, and thoracic auscultation become the primary monitoring tools. The Guide for the Care and Use of Laboratory Animals emphasizes that the institution must provide veterinary care consistent with the procedure's demands, so document the monitoring limitation in the protocol and justify why the procedure proceeds under these constraints. If the animal's condition deteriorates, the plan must include immediate steps to improve monitoring capability or terminate the procedure.

What Is the Minimum Pre-Anesthetic Workup for a Healthy Adult Rodent?

For an adult rodent with no abnormalities on history or physical examination, a minimal workup includes body weight, body condition score, hydration status, and thoracic auscultation. Pre-anesthetic blood work is not routinely indicated in healthy animals, but a baseline sample may be justified when the study protocol requires it or when the procedure is prolonged. The systematic well-being assessment protocol for mice demonstrates that simple measures such as home cage activity, nesting behavior, and the Mouse Grimace Scale can detect post-anesthetic compromise without invasive testing. If the physical examination reveals any abnormality, the workup expands to include hematology, serum biochemistry, or diagnostic imaging as indicated by the findings. Age and strain-specific susceptibilities should also inform the decision to pursue additional testing.

How Do I Communicate an Elevated Risk Classification to the Principal Investigator?

Frame the discussion around study validity and welfare, not administrative obstruction. Explain that an unanticipated death or a prolonged recovery introduces physiological variability that can confound experimental data, and that refinement of the anesthetic plan often improves both welfare and data quality. Present the specific risk factors identified, the proposed modifications, and the expected impact on outcomes. The NC3Rs resources on the 3Rs provide practical examples of how refinement strategies can be integrated into study design without compromising scientific objectives. If the investigator declines recommended changes, document the conversation, the rationale provided, and the final decision in the animal record. Escalate to the institutional animal care and use committee when the risk is severe and the disagreement cannot be resolved.

Does the Risk Assessment Differ Between Survival and Non-Recovery Procedures?

Yes, the assessment changes fundamentally. For non-recovery procedures, concerns about postoperative pain, delayed recovery, and long-term cognitive effects become irrelevant, but intraoperative risk remains fully relevant. Cardiovascular stability, depth of anesthesia, and thermoregulation still require attention because they affect data quality and the animal's experience before death. For survival procedures, the assessment must incorporate recovery-phase risks, including hypothermia, dehydration, and pain-related behavioral changes. Repeated anesthesia for imaging or other longitudinal studies adds another layer, since repeated ketamine-xylazine anesthesia has been shown to increase grimace scores and affect well-being in mice. The severity classification assigned under applicable regulations should reflect the cumulative burden of all anesthetic episodes, also the final procedure.

What Should I Do When a Research Animal Has a Known Cardiac or Respiratory Comorbidity?

Identify the specific functional limitation and match the anesthetic plan to it. For animals with echocardiographic evidence of reduced systolic function, avoid agents with pronounced negative inotropy and plan for a slower induction with lower peak drug concentrations. For animals with respiratory disease, minimize the duration of apnea and consider oxygen supplementation during induction and maintenance. The MSD Veterinary Manual provides species-specific guidance on anesthetic drug selection and physiologic considerations that apply to laboratory species. Consultation with a veterinary anesthesiologist is appropriate when the comorbidity is severe or when the planned procedure is lengthy. Document the functional status, the rationale for drug choices, and the specific monitoring parameters that will trigger intervention. If the comorbidity is progressive, schedule the procedure earlier in the disease course instead of waiting for full decompensation.

How Should I Document the Risk Assessment to Satisfy Regulatory and Institutional Review?

Record the assessment at the time it is performed, not retrospectively. Include the animal identification, body weight, physical examination findings, relevant history, the assigned risk classification, and the specific factors that influenced the classification. Note any deviations from standard protocols and the justification for those deviations. The AVMA practice resources and the Guide for the Care and Use of Laboratory Animals both emphasize that veterinary medical records must support the care provided and the decisions made. Record the monitoring parameters used, the drugs administered, and any complications that occurred. If the animal dies or is euthanized, document the circumstances and the relationship to the risk assessment. This record becomes the basis for post-procedure review and for refining future assessments.

Related Clinical & Scientific Guides

• Refining IACUC Protocols to Minimize Animal Pain and Distress
• Health Monitoring Programs for Laboratory Animal Facilities
• Selecting Animal Models for Infectious Disease Research

References and Further Reading

• Systematic Assessment of Well-Being in Mice for Procedures Using General Anesthesia.. 2018.
• Mechanistic insights aid the search for CFC substitutes: risk assessment of HCFC-123 as an example.. 1994.
• Establishing a health-based recommended occupational exposure limit for isoflurane using experimental animal data: a systematic review protocol.. 2023.
• An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function.. 2008.
• Impact of repeated anesthesia with ketamine and xylazine on the well-being of C57BL/6JRj mice.. 2018.
• Synthesis versus imitation: evaluation of a medical student simulation curriculum via Objective Structured Assessment of Technical Skill.. 2010.
• Guide for the Care and Use of Laboratory Animals, 8th Edition. National Academies Press, 2011.
• NC3Rs Resources on Replacement, Reduction and Refinement. NC3Rs.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Welfare Assessment Tools for Laboratory Rodents
• Anesthetic Considerations for Pregnant Laboratory Animals
• Welfare Assessment of Laboratory Fish: Beyond Zebrafish
• Pain Assessment in Laboratory Animals: Behavioral and Physiological Indicators
• Anesthesia for Laboratory Rabbits: Protocols and Monitoring

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.